Core Scientific, Inc. (CORZ) Balance Sheet

The balance sheet is expanding rapidly, but the equity deficit is widening at an even faster pace, suggesting that asset growth is being funded primarily through liabilities. This trend implies that the company's financial risk profile is deteriorating despite top-line growth, and investors should monitor whether this expansion translates into sustainable profitability.

The debt load has increased more than sixfold over the period, while equity remains deeply negative, making the company technically insolvent on a book value basis. This leverage appears strategic, aimed at funding infrastructure growth, but it exposes the company to significant refinancing risk and interest rate sensitivity, especially given the volatile cash flows from Bitcoin mining.

The substantial increase in property, plant, and equipment reflects a deliberate strategy to expand mining capacity, but it also raises the fixed-cost base and depreciation burden. The sudden appearance of goodwill in 2026Q2 suggests an acquisition, which may carry impairment risk if the acquired assets underperform, particularly in a volatile crypto market.

The widening deficit in retained earnings highlights the company's inability to generate sustainable profits, with cumulative losses exceeding $3.4B over the period. This negative equity position may constrain future financing options and signals that the company is reliant on external capital to fund operations, which could lead to dilution or further debt accumulation.

While the cash position has improved significantly, the current ratio dropping below 1.0 suggests that current liabilities now exceed current assets, which could strain liquidity if cash flows deteriorate. The company appears to be holding cash as a buffer against operational volatility, but the negative working capital position warrants close monitoring.